“Head and Neck Atopic Dermatitis: Therapeutic Response After Switching to Upadacitinib in Moderate-to-Severe Atopic Dermatitis Patients Who Had Inadequate Response to Dupilumab”. SKIN The Journal of Cutaneous Medicine, vol. 10, no. 2, Mar. 2026, p. s740, https://doi.org/10.25251/ztj3rn69.